Literature DB >> 20435941

Facemask pressure-controlled ventilation in children: what is the pressure limit?

Sylvaine Lagarde1, François Semjen, Karine Nouette-Gaulain, Françoise Masson, Maryline Bordes, Yves Meymat, Anne-Marie Cros.   

Abstract

BACKGROUND: In this study, we sought to determine the level of inspiratory pressures allowing adequate and safe ventilation without any risk of gastric insufflation (GI) in children according to age.
METHODS: One hundred children, aged 1 day to 16 years, ASA physical status I to II, scheduled for general anesthesia were studied prospectively. After induction of anesthesia, children's lungs were ventilated with pressure-controlled ventilation. The initial inspiratory pressure was 10 cm H(2)O and was increased by steps of 5 cm H(2)O, up to a maximum of 25 cm H(2)O. At each step, GI was detected by epigastric auscultation. The recorded data were age and weight. At each step, the inspiratory pressure, the respiratory rate, the expired tidal volume, the minute ventilation, and the occurrence of GI were also recorded.
RESULTS: GI occurred in 78 children. GI occurred in 95% of children younger than 1 year, in 93% of children aged 1 to 5 years, and 56% of children older than 5 years (P = 0.001). The pressure threshold at which GI occurred increased with age: the younger the child, the lower the GI pressure threshold. Tidal volume increased with inspiratory pressure, but at >15 cm H(2)O, tidal volume did not change significantly.
CONCLUSION: The inspiratory pressure threshold at which GI can occur depends on age. It is low in infants and increases with age. In most cases, proper ventilation without GI was obtained with an inspiratory pressure </=15 cm H(2)O. Increasing inspiratory pressure above this threshold results in an increase in GI and no change in tidal volume.

Entities:  

Mesh:

Year:  2010        PMID: 20435941     DOI: 10.1213/ANE.0b013e3181d8a14c

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Peak airway pressure is lower during pressure-controlled than during manual facemask ventilation for induction of anesthesia in pediatric patients-a randomized, clinical crossover trial.

Authors:  Ulrich Goebel; Stefan Schumann; Steffen Wirth
Journal:  J Anesth       Date:  2018-11-12       Impact factor: 2.078

2.  Inhibitory Effect of Nasal Intermittent Positive Pressure Ventilation on Gastroesophageal Reflux.

Authors:  Danny Cantin; Djamal Djeddi; Vincent Carrière; Nathalie Samson; Stéphanie Nault; Wan Lu Jia; Jennifer Beck; Jean-Paul Praud
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

3.  A randomized comparison of volume- and pressure-controlled ventilation in children with the i-gel: Effects on peak inspiratory pressure, oropharyngeal leak pressure, and gastric insufflation.

Authors:  Jin Ha Park; Ji Young Kim; Kyoungun Park; Hae Keum Kil
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

4.  Ultrasound-guided esophageal compression during mask ventilation in small children: a prospective observational study.

Authors:  Eun-Hee Kim; Sung-Ae Cho; Pyoyoon Kang; In-Sun Song; Sang-Hwan Ji; Young-Eun Jang; Ji-Hyun Lee; Jin-Tae Kim; Hee-Soo Kim
Journal:  BMC Anesthesiol       Date:  2022-08-15       Impact factor: 2.376

5.  Determination of the optimal inspiratory pressure providing adequate ventilation while minimizing gastric insufflation using real-time ultrasonography in Chinese children: a prospective, randomized, double-blind study.

Authors:  Xiaowei Qian; Qiong Hu; Hang Zhao; Bo Meng; Yang Nan; Hong Cao; Qingquan Lian; Jun Li
Journal:  BMC Anesthesiol       Date:  2017-09-11       Impact factor: 2.217

6.  Evaluation of Different Positive End-Expiratory Pressures Using Supreme™ Airway Laryngeal Mask during Minor Surgical Procedures in Children.

Authors:  Mascha O Fiedler; Elisabeth Schätzle; Marius Contzen; Christian Gernoth; Christel Weiß; Thomas Walter; Tim Viergutz; Armin Kalenka
Journal:  Medicina (Kaunas)       Date:  2020-10-21       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.